Medipharm Labs Company Executives
LABS Stock | CAD 0.07 0.01 7.69% |
Medipharm Labs employs about 166 people. The company is managed by 21 executives with a total tenure of roughly 66 years, averaging almost 3.0 years of service per executive, having 7.9 employees per reported executive. Analysis of Medipharm Labs' management performance can provide insight into the firm performance.
Medipharm |
Medipharm Labs Management Team Effectiveness
The company has return on total asset (ROA) of (0.0717) % which means that it has lost $0.0717 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2496) %, meaning that it generated substantial loss on money invested by shareholders. Medipharm Labs' management efficiency ratios could be used to measure how well Medipharm Labs manages its routine affairs as well as how well it operates its assets and liabilities. As of the 18th of January 2025, Return On Tangible Assets is likely to drop to -0.2. In addition to that, Return On Capital Employed is likely to drop to -0.42. At this time, Medipharm Labs' Total Assets are very stable compared to the past year. As of the 18th of January 2025, Total Current Assets is likely to grow to about 52 M, while Net Tangible Assets are likely to drop about 59.3 M.As of the 18th of January 2025, Common Stock Shares Outstanding is likely to grow to about 438.7 M, while Net Loss is likely to drop (28.3 M).
Medipharm Labs Workforce Comparison
Medipharm Labs Corp is rated second overall in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 1,244. Medipharm Labs retains roughly 166 in number of employees claiming about 13% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.35) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.23) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.23. Medipharm Labs Corp Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Medipharm Labs Corp Price Series Summation is a cross summation of Medipharm Labs price series and its benchmark/peer.
Medipharm Labs Notable Stakeholders
A Medipharm Labs stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Medipharm Labs often face trade-offs trying to please all of them. Medipharm Labs' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Medipharm Labs' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Patrick McCutcheon | Chairman of the Board, Chief Executive Officer and Director | Profile | |
Robert Kwon | Chief Financial Officer | Profile | |
David Mayers | Chief Operating Officer | Profile | |
Shelley Martin | Independent Director | Profile | |
Saravan Subramaniam | Vice Chain | Profile | |
Nigel Dewsbury | Head Quality | Profile | |
Geoffrey Marr | Executive Counsel | Profile | |
Brett Moon | Vice Sales | Profile | |
Kirk Binns | Executive Accounts | Profile | |
Sybil Taylor | Chief Marketing Officer | Profile | |
Paul Tam | Director | Profile | |
Chris Halyk | Independent Director | Profile | |
Miriam McDonald | Director | Profile | |
David Pidduck | CEO Director | Profile | |
Keith Strachan | President Director | Profile | |
Greg Hunter | Chief Officer | Profile | |
Warren Everitt | Managing Director - MediPharm Labs Australia | Profile | |
Chris Taves | Director | Profile | |
Christopher Hobbs | Director | Profile | |
Braden Fenske | Chief Strategy Officer | Profile | |
Marufur Raza | Director | Profile |
About Medipharm Labs Management Performance
The success or failure of an entity such as Medipharm Labs Corp often depends on how effective the management is. Medipharm Labs management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Medipharm management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Medipharm management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.19) | (0.20) | |
Return On Capital Employed | (0.40) | (0.42) | |
Return On Assets | (0.18) | (0.19) | |
Return On Equity | (0.22) | (0.23) |
Medipharm Labs Workforce Analysis
Traditionally, organizations such as Medipharm Labs use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Medipharm Labs within its industry.Medipharm Labs Manpower Efficiency
Return on Medipharm Labs Manpower
Revenue Per Employee | 199.2K | |
Revenue Per Executive | 1.6M | |
Net Loss Per Employee | 78.8K | |
Net Loss Per Executive | 623K | |
Working Capital Per Employee | 155.2K | |
Working Capital Per Executive | 1.2M |
Other Information on Investing in Medipharm Stock
Medipharm Labs financial ratios help investors to determine whether Medipharm Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipharm with respect to the benefits of owning Medipharm Labs security.